Personalis, Inc. financial data

Symbol
PSNL on Nasdaq
Industry
Services-Medical Laboratories
Location
6600 Dumbarton Circle, Fremont, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 369 % -31.5%
Debt-to-equity 59.8 % +46.7%
Return On Equity -69.1 % -13.2%
Return On Assets -43.3 % +0.25%
Operating Margin -84.7 % +49.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70.6M shares +44.1%
Common Stock, Shares, Outstanding 70.6M shares +44.1%
Entity Public Float 90.6B USD +57977%
Weighted Average Number of Shares Outstanding, Basic 61.1M shares +25.4%
Weighted Average Number of Shares Outstanding, Diluted 61.1M shares +25.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 87.5M USD +24%
Cost of Revenue 60M USD +8.69%
Research and Development Expense 51M USD -24.7%
Costs and Expenses 162M USD -14.3%
Operating Income (Loss) -74.1M USD +37.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -91.4M USD +18.9%
Income Tax Expense (Benefit) 19K USD -77.9%
Net Income (Loss) Attributable to Parent -91.4M USD +18.9%
Earnings Per Share, Basic -1.68 USD/shares +29.4%
Earnings Per Share, Diluted -1.68 USD/shares +29.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 75.8M USD +5%
Accounts Receivable, after Allowance for Credit Loss, Current 13.5M USD -1.41%
Assets, Current 170M USD +14.9%
Property, Plant and Equipment, Net 50.2M USD -11.5%
Operating Lease, Right-of-Use Asset 16.8M USD -7.44%
Other Assets, Noncurrent 2.56M USD -26.8%
Assets 240M USD +5.85%
Accounts Payable, Current 12.5M USD +38.9%
Employee-related Liabilities, Current 8.16M USD -6.94%
Accrued Liabilities, Current 1.47M USD -25.5%
Contract with Customer, Liability, Current 3.43M USD -7.2%
Liabilities, Current 36.4M USD +12.1%
Contract with Customer, Liability, Noncurrent 150K USD
Operating Lease, Liability, Noncurrent 35.6M USD -9.1%
Other Liabilities, Noncurrent 1.11M USD -70.6%
Liabilities 73.1M USD -3.05%
Accumulated Other Comprehensive Income (Loss), Net of Tax 87K USD
Retained Earnings (Accumulated Deficit) -534M USD -20.7%
Stockholders' Equity Attributable to Parent 167M USD +10.3%
Liabilities and Equity 240M USD +5.85%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.4M USD -29.6%
Net Cash Provided by (Used in) Financing Activities 1.13M USD
Net Cash Provided by (Used in) Investing Activities 6.3M USD -54.3%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 70.6M shares +44.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -13M USD -565%
Deferred Tax Assets, Valuation Allowance 145M USD +26.5%
Deferred Tax Assets, Gross 150M USD +22.7%
Operating Lease, Liability 43.5M USD -7.18%
Payments to Acquire Property, Plant, and Equipment 104K USD -97.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -91.1M USD +18.5%
Lessee, Operating Lease, Liability, to be Paid 72.6M USD -10%
Property, Plant and Equipment, Gross 95M USD +6.95%
Operating Lease, Liability, Current 7.91M USD +2.57%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.23M USD -10.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.06M USD -0.95%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.19M USD -0.57%
Deferred Tax Assets, Operating Loss Carryforwards 84M USD +16%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 5.7M USD +34.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.22M USD -27.5%
Operating Lease, Payments 2M USD +150%
Depreciation, Depletion and Amortization 11.4M USD +0.12%
Deferred Tax Assets, Net of Valuation Allowance 5.2M USD -33.5%
Share-based Payment Arrangement, Expense 11.4M USD -30.7%
Interest Expense 34K USD -77%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%